- Home
- OGI vs PLX Comparison
OGI vs PLX Comparison
Compare OGI & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OGI | PLX |
|---|---|---|
| Founded | 2013 | 1993 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.3M | 182.9M |
| IPO Year | 2015 | 1996 |
Fundamental Metrics
Financial Performance| Metric | OGI | PLX |
|---|---|---|
| Price | $1.15 | $2.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 1.0M | 757.1K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $52,744,000.00 |
| Revenue This Year | $20.10 | $36.81 |
| Revenue Next Year | $13.92 | N/A |
| P/E Ratio | $13.91 | ★ $9.69 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.85 | $1.53 |
| 52 Week High | $2.24 | $3.19 |
Technical Indicators
Market Signals| Indicator | OGI | PLX |
|---|---|---|
| Relative Strength Index (RSI) | 48.72 | 62.68 |
| Support Level | $0.92 | $2.59 |
| Resistance Level | $1.21 | $2.71 |
| Average True Range (ATR) | 0.05 | 0.09 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 9.37 | 87.78 |
Price Performance
Historical ComparisonAbout OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.